Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Pharmaceuticals - Everolimus and terminated agreement products

The NHS Commissioning Board (operating under the name of NHS England)

This public procurement record has 2 releases in its history.

Award

28 Sep 2021 at 12:36

Award Notice
Tender

09 Apr 2021 at 15:35

Tender Notice
Summary of the contracting process

The procurement process initiated by the NHS Commissioning Board (operating under NHS England) involves a tender titled "NHS National Pharmaceuticals - Everolimus and terminated agreement products," which falls under the pharmaceutical products category (CPV code 33600000). The procurement is currently in the active stage, with potential call-offs across various regions set to commence as soon as possible, with the end dates for different products ranging from January to March 2022. The total estimated value for this framework agreement is approximately £18.72 million. Interested suppliers must submit their bids electronically via the specified eTendering portal before the tender period ends on 26 April 2021.

This tender presents significant opportunities for growth in the pharmaceutical sector, particularly for small and medium-sized enterprises (SMEs) offering products such as Everolimus and related goods. Companies focused on high-quality pharmaceuticals are well-suited to compete, especially given the NHS's ongoing demand for competitive supply and products related to critical care medicines. Businesses that can demonstrate compliance with the selection criteria and provide exceptional value in their offerings may find this tender to be a pathway to securing contracts within the NHS framework.

How relevant is this notice?

Notice Information

Notice Title

NHS National Pharmaceuticals - Everolimus and terminated agreement products

Notice Description

Potential periods of call-offs under the framework agreement:Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022

Lot Information

Lot 1 - CM/PHG/21/5632/00 Everolimus

Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632/00Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Lot 2 - CM/PHG/21/5632/01 Oral (plus non parenteral) products

Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Lot 3 - CM/PHG/21/5632/02 Hospital Only products

Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement productsOffer reference number: CM/PHG/21/5632Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.Potential periods of call-offs under the framework agreement:Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02a471
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/024061-2021
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£18,720,512 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
28 Sep 20214 years ago
Submission Deadline
26 Apr 2021Expired
Future Notice Date
Not specified
Award Date
8 Jun 20215 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The NHS Commissioning Board (operating under the name of NHS England)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
Not specified
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
15
Supplier Names

Accord-UK Ltd

Bowmed Ibisqus Limited

Bristol Laboratories Limited

Crescent Pharma Ltd

Dr.Reddy's Laboratories (UK) Limited

Drugsrus Ltd

Fresenius Kabi Limited

Martindale Pharma

Medreich PLC

Milpharm Ltd/aurobinbdo

Mylan

Ranbaxy UK

Selective Supplies Ltd.

Teva UK Limited

Torrent Pharma UK Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...